Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Behavior, Animal | 37 | 2021 | 1881 | 4.050 |
Why?
|
Saimiri | 65 | 2021 | 330 | 3.870 |
Why?
|
Discrimination Learning | 27 | 2021 | 280 | 3.800 |
Why?
|
Cocaine | 41 | 2021 | 1007 | 2.920 |
Why?
|
Methamphetamine | 13 | 2021 | 154 | 2.740 |
Why?
|
Conditioning, Operant | 22 | 2021 | 313 | 2.350 |
Why?
|
Nicotine | 8 | 2019 | 681 | 2.300 |
Why?
|
Receptor, Cannabinoid, CB1 | 10 | 2020 | 143 | 2.220 |
Why?
|
Receptors, Dopamine D1 | 20 | 2007 | 291 | 2.160 |
Why?
|
Nicotinic Agonists | 5 | 2021 | 271 | 1.710 |
Why?
|
Dopamine Agonists | 17 | 2012 | 355 | 1.680 |
Why?
|
Central Nervous System Stimulants | 13 | 2021 | 1148 | 1.670 |
Why?
|
Dopamine Agents | 9 | 2014 | 189 | 1.670 |
Why?
|
Behavior, Addictive | 7 | 2019 | 462 | 1.460 |
Why?
|
Dose-Response Relationship, Drug | 58 | 2024 | 10949 | 1.460 |
Why?
|
Self Administration | 30 | 2021 | 386 | 1.460 |
Why?
|
Dopamine Uptake Inhibitors | 12 | 2019 | 312 | 1.380 |
Why?
|
Benzazepines | 17 | 2018 | 326 | 1.350 |
Why?
|
Substance Withdrawal Syndrome | 5 | 2019 | 632 | 1.340 |
Why?
|
Dopamine Antagonists | 12 | 2015 | 296 | 1.330 |
Why?
|
Cannabinoids | 6 | 2022 | 166 | 1.330 |
Why?
|
Receptors, Dopamine D2 | 13 | 2008 | 475 | 1.300 |
Why?
|
Reversal Learning | 4 | 2016 | 60 | 1.240 |
Why?
|
Macaca mulatta | 25 | 2024 | 2378 | 1.240 |
Why?
|
Analgesics, Opioid | 10 | 2024 | 3674 | 1.100 |
Why?
|
Substance-Related Disorders | 15 | 2019 | 4259 | 1.080 |
Why?
|
Food | 7 | 2019 | 770 | 1.080 |
Why?
|
Receptors, Opioid, mu | 9 | 2024 | 182 | 1.000 |
Why?
|
Alkaloids | 4 | 2021 | 190 | 0.990 |
Why?
|
Naltrexone | 7 | 2024 | 307 | 0.900 |
Why?
|
Receptors, Dopamine D4 | 2 | 2015 | 171 | 0.890 |
Why?
|
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine | 9 | 2006 | 54 | 0.880 |
Why?
|
Animals | 137 | 2024 | 168788 | 0.850 |
Why?
|
Reinforcement Schedule | 17 | 2017 | 129 | 0.840 |
Why?
|
Buspirone | 2 | 2012 | 82 | 0.830 |
Why?
|
Drug Interactions | 18 | 2020 | 1458 | 0.800 |
Why?
|
Biology | 1 | 2023 | 294 | 0.780 |
Why?
|
Cocaine-Related Disorders | 9 | 2019 | 460 | 0.750 |
Why?
|
Arachidonic Acids | 4 | 2020 | 300 | 0.710 |
Why?
|
Amphetamine-Related Disorders | 2 | 2018 | 67 | 0.700 |
Why?
|
Piperidines | 7 | 2022 | 1605 | 0.690 |
Why?
|
Pharmacology | 4 | 2021 | 103 | 0.680 |
Why?
|
Endocannabinoids | 3 | 2017 | 116 | 0.680 |
Why?
|
Cannabidiol | 2 | 2021 | 106 | 0.660 |
Why?
|
Disulfiram | 1 | 2018 | 57 | 0.640 |
Why?
|
Cannabinol | 3 | 2017 | 9 | 0.630 |
Why?
|
Neuroimmunomodulation | 1 | 2019 | 157 | 0.630 |
Why?
|
Heroin | 1 | 2018 | 117 | 0.630 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2021 | 365 | 0.600 |
Why?
|
Psychomotor Performance | 5 | 2021 | 1901 | 0.600 |
Why?
|
Pyrazoles | 7 | 2022 | 1973 | 0.600 |
Why?
|
Polyunsaturated Alkamides | 2 | 2017 | 29 | 0.590 |
Why?
|
Vaccines | 2 | 2016 | 822 | 0.570 |
Why?
|
Behavioral Symptoms | 1 | 2018 | 175 | 0.560 |
Why?
|
Cognition | 7 | 2021 | 6765 | 0.560 |
Why?
|
Behavior | 5 | 2021 | 560 | 0.560 |
Why?
|
Nitrates | 1 | 2018 | 265 | 0.560 |
Why?
|
Computers, Handheld | 1 | 2017 | 208 | 0.530 |
Why?
|
Drug Discovery | 1 | 2023 | 1058 | 0.520 |
Why?
|
Narcotic Antagonists | 5 | 2024 | 562 | 0.510 |
Why?
|
Receptors, Dopamine D3 | 2 | 2012 | 110 | 0.510 |
Why?
|
Receptors, Nicotinic | 2 | 2018 | 497 | 0.500 |
Why?
|
Touch | 2 | 2017 | 306 | 0.490 |
Why?
|
Eating | 5 | 2018 | 1538 | 0.490 |
Why?
|
Smoke | 1 | 2016 | 227 | 0.480 |
Why?
|
Psychopharmacology | 3 | 2009 | 143 | 0.460 |
Why?
|
Dopamine | 7 | 2018 | 1591 | 0.450 |
Why?
|
Wakefulness | 4 | 2022 | 1245 | 0.440 |
Why?
|
Selegiline | 3 | 2005 | 31 | 0.430 |
Why?
|
Adamantane | 2 | 2017 | 174 | 0.430 |
Why?
|
Reaction Time | 8 | 2021 | 2102 | 0.420 |
Why?
|
Psychology | 1 | 2014 | 356 | 0.420 |
Why?
|
Drug-Seeking Behavior | 5 | 2024 | 48 | 0.410 |
Why?
|
Neuropsychological Tests | 3 | 2021 | 6991 | 0.410 |
Why?
|
Serotonin Receptor Agonists | 1 | 2012 | 154 | 0.400 |
Why?
|
Pyrrolidines | 6 | 2021 | 342 | 0.390 |
Why?
|
Biogenic Monoamines | 2 | 2010 | 50 | 0.390 |
Why?
|
Male | 88 | 2024 | 350027 | 0.380 |
Why?
|
Tobacco Use Disorder | 2 | 2016 | 688 | 0.380 |
Why?
|
Blinking | 3 | 2007 | 138 | 0.370 |
Why?
|
Amphetamines | 2 | 2005 | 148 | 0.370 |
Why?
|
Pain Threshold | 1 | 2014 | 585 | 0.370 |
Why?
|
Immunization | 1 | 2015 | 1256 | 0.370 |
Why?
|
Cholinergic Agents | 1 | 2010 | 93 | 0.370 |
Why?
|
Receptors, Opioid | 5 | 2022 | 155 | 0.360 |
Why?
|
Anti-Anxiety Agents | 1 | 2012 | 390 | 0.360 |
Why?
|
Nanotechnology | 1 | 2016 | 710 | 0.360 |
Why?
|
Diuretics | 1 | 2012 | 592 | 0.340 |
Why?
|
Membrane Transport Proteins | 3 | 2017 | 1028 | 0.340 |
Why?
|
Buprenorphine | 3 | 2019 | 640 | 0.340 |
Why?
|
GABA-A Receptor Agonists | 4 | 2003 | 84 | 0.340 |
Why?
|
Psychotropic Drugs | 3 | 2021 | 894 | 0.330 |
Why?
|
Behavioral Research | 1 | 2008 | 54 | 0.320 |
Why?
|
Morphinans | 2 | 2023 | 31 | 0.320 |
Why?
|
Clinical Laboratory Techniques | 1 | 2013 | 738 | 0.310 |
Why?
|
Drug Tolerance | 6 | 2021 | 376 | 0.310 |
Why?
|
Drug Partial Agonism | 2 | 2019 | 25 | 0.300 |
Why?
|
Receptors, Opioid, kappa | 5 | 2007 | 144 | 0.290 |
Why?
|
Pyridines | 4 | 2021 | 2822 | 0.290 |
Why?
|
Choice Behavior | 3 | 2015 | 803 | 0.290 |
Why?
|
Electroshock | 7 | 2012 | 122 | 0.290 |
Why?
|
Opioid-Related Disorders | 4 | 2024 | 2065 | 0.280 |
Why?
|
Drug Delivery Systems | 2 | 2016 | 2218 | 0.280 |
Why?
|
Ligands | 8 | 2022 | 3294 | 0.270 |
Why?
|
Muscarinic Antagonists | 2 | 2021 | 137 | 0.270 |
Why?
|
Drug Synergism | 2 | 2021 | 1791 | 0.270 |
Why?
|
Piperazines | 6 | 2010 | 2491 | 0.270 |
Why?
|
Motor Activity | 3 | 2017 | 2714 | 0.270 |
Why?
|
Immunologic Factors | 1 | 2015 | 1582 | 0.260 |
Why?
|
Dextroamphetamine | 6 | 2010 | 129 | 0.260 |
Why?
|
Quinolones | 1 | 2008 | 367 | 0.260 |
Why?
|
Benzofurans | 2 | 2007 | 140 | 0.260 |
Why?
|
Disease Models, Animal | 6 | 2019 | 18027 | 0.260 |
Why?
|
Amphetamine | 4 | 2020 | 225 | 0.250 |
Why?
|
Nicotinic Antagonists | 2 | 2018 | 96 | 0.250 |
Why?
|
Membrane Transport Modulators | 1 | 2004 | 24 | 0.250 |
Why?
|
Nalbuphine | 2 | 2021 | 20 | 0.250 |
Why?
|
Oxycodone | 3 | 2024 | 153 | 0.250 |
Why?
|
N-Methyl-3,4-methylenedioxyamphetamine | 2 | 2021 | 65 | 0.240 |
Why?
|
Receptors, Opioid, delta | 2 | 2022 | 47 | 0.240 |
Why?
|
Nucleus Accumbens | 3 | 2018 | 366 | 0.240 |
Why?
|
Smoking Cessation | 1 | 2016 | 2071 | 0.230 |
Why?
|
Phenethylamines | 2 | 2001 | 100 | 0.230 |
Why?
|
Morphine | 6 | 2023 | 657 | 0.230 |
Why?
|
Periodicals as Topic | 2 | 2020 | 1432 | 0.230 |
Why?
|
Midazolam | 3 | 2003 | 270 | 0.230 |
Why?
|
Oxazines | 5 | 2004 | 298 | 0.220 |
Why?
|
Dopamine Plasma Membrane Transport Proteins | 3 | 2021 | 422 | 0.220 |
Why?
|
Membrane Glycoproteins | 2 | 2004 | 3769 | 0.220 |
Why?
|
Motivation | 3 | 2016 | 1971 | 0.220 |
Why?
|
Pain | 3 | 2020 | 4987 | 0.220 |
Why?
|
Rats | 14 | 2021 | 24273 | 0.220 |
Why?
|
Psychophysiology | 1 | 2002 | 135 | 0.210 |
Why?
|
Narcotics | 2 | 1996 | 343 | 0.210 |
Why?
|
Receptor, Serotonin, 5-HT2C | 2 | 2018 | 44 | 0.200 |
Why?
|
History, 20th Century | 4 | 2014 | 2739 | 0.200 |
Why?
|
Rats, Sprague-Dawley | 8 | 2016 | 8302 | 0.200 |
Why?
|
Fentanyl | 2 | 2022 | 410 | 0.200 |
Why?
|
Monoamine Oxidase Inhibitors | 1 | 2001 | 158 | 0.200 |
Why?
|
Monoamine Oxidase | 1 | 2001 | 178 | 0.190 |
Why?
|
Drug Evaluation, Preclinical | 3 | 2019 | 1372 | 0.190 |
Why?
|
Injections, Intramuscular | 5 | 2017 | 548 | 0.190 |
Why?
|
Levorphanol | 4 | 2010 | 10 | 0.190 |
Why?
|
Microdialysis | 3 | 2017 | 158 | 0.190 |
Why?
|
GABA Agonists | 1 | 2000 | 111 | 0.190 |
Why?
|
Callithrix | 2 | 2021 | 93 | 0.180 |
Why?
|
Adrenergic Uptake Inhibitors | 2 | 2015 | 189 | 0.180 |
Why?
|
Hydromorphone | 1 | 2020 | 65 | 0.180 |
Why?
|
Inflammation | 1 | 2019 | 10634 | 0.180 |
Why?
|
Behavioral Medicine | 1 | 2020 | 50 | 0.180 |
Why?
|
Drug Design | 2 | 2014 | 1078 | 0.180 |
Why?
|
Receptors, GABA-A | 2 | 2001 | 627 | 0.180 |
Why?
|
Rodentia | 1 | 2021 | 262 | 0.180 |
Why?
|
Acetamides | 1 | 2001 | 249 | 0.170 |
Why?
|
Benzopyrans | 1 | 2019 | 66 | 0.170 |
Why?
|
Serotonin Plasma Membrane Transport Proteins | 2 | 2021 | 322 | 0.170 |
Why?
|
Structure-Activity Relationship | 7 | 2020 | 3133 | 0.170 |
Why?
|
Electroencephalography | 4 | 2022 | 6150 | 0.170 |
Why?
|
Scalp | 1 | 2022 | 380 | 0.170 |
Why?
|
Catalepsy | 2 | 1998 | 34 | 0.170 |
Why?
|
Hypercapnia | 1 | 2020 | 260 | 0.160 |
Why?
|
Excitatory Amino Acid Antagonists | 1 | 2021 | 449 | 0.160 |
Why?
|
Antiemetics | 1 | 2020 | 176 | 0.160 |
Why?
|
Binding, Competitive | 7 | 2020 | 1159 | 0.160 |
Why?
|
Reward | 3 | 2021 | 941 | 0.160 |
Why?
|
Feeding Behavior | 5 | 2016 | 3188 | 0.160 |
Why?
|
Injections, Intravenous | 5 | 2017 | 1420 | 0.160 |
Why?
|
Caffeine | 1 | 2002 | 699 | 0.150 |
Why?
|
Self Stimulation | 1 | 2017 | 55 | 0.150 |
Why?
|
Clozapine | 3 | 1997 | 498 | 0.150 |
Why?
|
Hallucinogens | 1 | 2021 | 183 | 0.150 |
Why?
|
Neuropeptides | 1 | 2003 | 942 | 0.150 |
Why?
|
Primates | 4 | 2022 | 544 | 0.150 |
Why?
|
Norepinephrine Plasma Membrane Transport Proteins | 1 | 2017 | 66 | 0.150 |
Why?
|
Acetylcysteine | 1 | 2019 | 272 | 0.150 |
Why?
|
Corpus Striatum | 1 | 2024 | 1220 | 0.150 |
Why?
|
Excitatory Amino Acid Transporter 2 | 1 | 2018 | 77 | 0.150 |
Why?
|
Monoacylglycerol Lipases | 1 | 2017 | 48 | 0.150 |
Why?
|
Drug Industry | 1 | 2003 | 745 | 0.150 |
Why?
|
Serotonin | 3 | 2017 | 1023 | 0.150 |
Why?
|
Ethylketocyclazocine | 2 | 2007 | 4 | 0.150 |
Why?
|
Histamine H1 Antagonists | 2 | 1988 | 100 | 0.150 |
Why?
|
Pain Measurement | 2 | 2019 | 3419 | 0.150 |
Why?
|
Racemases and Epimerases | 1 | 2017 | 113 | 0.150 |
Why?
|
Drug Substitution | 1 | 2019 | 281 | 0.140 |
Why?
|
Receptors, Cannabinoid | 1 | 2016 | 44 | 0.140 |
Why?
|
Amidohydrolases | 1 | 2017 | 169 | 0.140 |
Why?
|
Anabasine | 1 | 2016 | 6 | 0.140 |
Why?
|
Methylphenidate | 4 | 2010 | 473 | 0.140 |
Why?
|
Analysis of Variance | 3 | 2015 | 6367 | 0.140 |
Why?
|
Respiratory Insufficiency | 2 | 2022 | 1199 | 0.140 |
Why?
|
Benzhydryl Compounds | 1 | 2022 | 845 | 0.130 |
Why?
|
Locomotion | 1 | 2018 | 378 | 0.130 |
Why?
|
Drugs, Investigational | 1 | 2017 | 214 | 0.130 |
Why?
|
Neurotransmitter Agents | 1 | 2019 | 647 | 0.130 |
Why?
|
Cotinine | 1 | 2016 | 206 | 0.130 |
Why?
|
Analgesics | 3 | 2013 | 1040 | 0.130 |
Why?
|
Naphthalenes | 2 | 2013 | 194 | 0.130 |
Why?
|
Ketamine | 1 | 2021 | 500 | 0.130 |
Why?
|
Berberine | 1 | 2015 | 25 | 0.130 |
Why?
|
Brain | 9 | 2022 | 26413 | 0.130 |
Why?
|
Photic Stimulation | 3 | 2021 | 2027 | 0.130 |
Why?
|
3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer | 3 | 2010 | 24 | 0.120 |
Why?
|
Benzoxazines | 2 | 2013 | 301 | 0.120 |
Why?
|
Carbamates | 1 | 2016 | 196 | 0.120 |
Why?
|
Tetrahydroisoquinolines | 1 | 1994 | 91 | 0.120 |
Why?
|
Respiration | 3 | 1996 | 1651 | 0.120 |
Why?
|
Humans | 43 | 2024 | 744220 | 0.120 |
Why?
|
Receptor, Cannabinoid, CB2 | 1 | 2013 | 49 | 0.120 |
Why?
|
Kynurenic Acid | 1 | 2013 | 45 | 0.120 |
Why?
|
Phencyclidine | 2 | 2021 | 61 | 0.120 |
Why?
|
Benzodiazepines | 2 | 1999 | 1101 | 0.120 |
Why?
|
Kinetics | 2 | 2018 | 6474 | 0.110 |
Why?
|
Nerve Tissue Proteins | 2 | 2017 | 4465 | 0.110 |
Why?
|
Hypnotics and Sedatives | 1 | 2001 | 1161 | 0.110 |
Why?
|
Appetite Stimulants | 1 | 2012 | 13 | 0.110 |
Why?
|
Chlorpheniramine | 2 | 1990 | 13 | 0.110 |
Why?
|
Gastrointestinal Tract | 1 | 2019 | 814 | 0.110 |
Why?
|
Stereoisomerism | 4 | 2006 | 625 | 0.110 |
Why?
|
Overnutrition | 1 | 2012 | 26 | 0.110 |
Why?
|
Drug Administration Schedule | 2 | 2016 | 4929 | 0.110 |
Why?
|
Morpholines | 2 | 2013 | 573 | 0.110 |
Why?
|
G Protein-Coupled Inwardly-Rectifying Potassium Channels | 1 | 2012 | 64 | 0.110 |
Why?
|
Diuresis | 1 | 2012 | 116 | 0.110 |
Why?
|
Pentobarbital | 2 | 2010 | 155 | 0.110 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2017 | 720 | 0.110 |
Why?
|
Butyrylcholinesterase | 1 | 2012 | 22 | 0.110 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2017 | 895 | 0.100 |
Why?
|
HEK293 Cells | 4 | 2016 | 4201 | 0.100 |
Why?
|
Memory, Short-Term | 2 | 2016 | 975 | 0.100 |
Why?
|
Tritium | 1 | 2012 | 746 | 0.100 |
Why?
|
Appetite Depressants | 1 | 2012 | 110 | 0.100 |
Why?
|
Basal Ganglia | 1 | 2015 | 545 | 0.100 |
Why?
|
Antipsychotic Agents | 3 | 2008 | 3058 | 0.100 |
Why?
|
Stress, Physiological | 1 | 2019 | 1404 | 0.100 |
Why?
|
Oxytocin | 1 | 2015 | 394 | 0.100 |
Why?
|
Haloperidol | 2 | 1994 | 397 | 0.100 |
Why?
|
Mecamylamine | 1 | 2010 | 29 | 0.100 |
Why?
|
Benzodioxoles | 2 | 2021 | 69 | 0.100 |
Why?
|
Neurotransmitter Uptake Inhibitors | 2 | 1989 | 37 | 0.090 |
Why?
|
Naloxone | 3 | 1996 | 367 | 0.090 |
Why?
|
Flumazenil | 2 | 2001 | 85 | 0.090 |
Why?
|
Physical Stimulation | 1 | 2012 | 525 | 0.090 |
Why?
|
Propiophenones | 3 | 2021 | 30 | 0.090 |
Why?
|
Benzomorphans | 2 | 1989 | 5 | 0.090 |
Why?
|
Learning | 2 | 2020 | 1713 | 0.090 |
Why?
|
Desipramine | 3 | 2005 | 184 | 0.090 |
Why?
|
Chlordiazepoxide | 2 | 1986 | 42 | 0.090 |
Why?
|
Diazepam | 3 | 2003 | 205 | 0.090 |
Why?
|
Benzamides | 1 | 2016 | 1378 | 0.090 |
Why?
|
Protein Binding | 4 | 2021 | 9392 | 0.090 |
Why?
|
Central Nervous System Agents | 1 | 2010 | 72 | 0.090 |
Why?
|
Gene Deletion | 1 | 2018 | 2751 | 0.090 |
Why?
|
Body Temperature | 1 | 2012 | 777 | 0.090 |
Why?
|
Pyrimidines | 1 | 2001 | 2940 | 0.080 |
Why?
|
Kwashiorkor | 1 | 1988 | 24 | 0.080 |
Why?
|
Albumins | 1 | 2012 | 569 | 0.080 |
Why?
|
Antidepressive Agents | 1 | 2021 | 2839 | 0.080 |
Why?
|
Cholinesterase Inhibitors | 1 | 2010 | 239 | 0.080 |
Why?
|
Genetics, Behavioral | 1 | 2008 | 53 | 0.080 |
Why?
|
Social Behavior | 1 | 2015 | 1127 | 0.080 |
Why?
|
Norepinephrine | 2 | 2017 | 909 | 0.080 |
Why?
|
Carbolines | 2 | 2001 | 265 | 0.080 |
Why?
|
Avoidance Learning | 1 | 2010 | 233 | 0.080 |
Why?
|
Quinoxalines | 1 | 2010 | 290 | 0.080 |
Why?
|
Hot Temperature | 1 | 2014 | 1355 | 0.080 |
Why?
|
Haplorhini | 1 | 2008 | 552 | 0.080 |
Why?
|
Extracellular Space | 1 | 2010 | 594 | 0.080 |
Why?
|
Cognition Disorders | 1 | 2022 | 4041 | 0.080 |
Why?
|
Mice | 9 | 2022 | 81178 | 0.080 |
Why?
|
Extinction, Psychological | 2 | 2019 | 376 | 0.080 |
Why?
|
Female | 22 | 2024 | 380197 | 0.070 |
Why?
|
Confidence Intervals | 1 | 2012 | 2970 | 0.070 |
Why?
|
Enzyme Inhibitors | 1 | 2017 | 3800 | 0.070 |
Why?
|
Cyclazocine | 1 | 1985 | 10 | 0.070 |
Why?
|
Generalization, Stimulus | 1 | 2005 | 13 | 0.070 |
Why?
|
Water | 1 | 2012 | 1395 | 0.070 |
Why?
|
Phenanthridines | 2 | 1996 | 51 | 0.070 |
Why?
|
Molecular Structure | 3 | 2016 | 1907 | 0.070 |
Why?
|
Nalorphine | 1 | 1985 | 5 | 0.070 |
Why?
|
History, 21st Century | 1 | 2011 | 1534 | 0.060 |
Why?
|
Attention | 1 | 2016 | 2399 | 0.060 |
Why?
|
Morphine Dependence | 1 | 1985 | 31 | 0.060 |
Why?
|
GABA Modulators | 2 | 2003 | 107 | 0.060 |
Why?
|
Vesicular Biogenic Amine Transport Proteins | 1 | 2003 | 9 | 0.060 |
Why?
|
Association Learning | 1 | 2005 | 224 | 0.060 |
Why?
|
Chlorides | 1 | 1986 | 667 | 0.060 |
Why?
|
Lithium | 1 | 1986 | 601 | 0.060 |
Why?
|
Nanoparticles | 1 | 2015 | 1905 | 0.060 |
Why?
|
Mental Disorders | 2 | 2019 | 6601 | 0.060 |
Why?
|
CHO Cells | 2 | 2022 | 1407 | 0.060 |
Why?
|
Neurons | 2 | 2024 | 9335 | 0.060 |
Why?
|
Conditioning, Classical | 1 | 2005 | 366 | 0.050 |
Why?
|
Depressive Disorder, Major | 1 | 2020 | 4645 | 0.050 |
Why?
|
Cricetinae | 2 | 2022 | 2472 | 0.050 |
Why?
|
Probability Learning | 1 | 2021 | 23 | 0.050 |
Why?
|
Pentanones | 1 | 2021 | 12 | 0.050 |
Why?
|
GABA Antagonists | 1 | 2001 | 128 | 0.050 |
Why?
|
Tremor | 1 | 2022 | 175 | 0.050 |
Why?
|
Sodium Chloride | 1 | 2003 | 625 | 0.050 |
Why?
|
Time Factors | 4 | 2015 | 40063 | 0.050 |
Why?
|
Scopolamine | 1 | 2021 | 99 | 0.050 |
Why?
|
Salivation | 1 | 2020 | 22 | 0.050 |
Why?
|
Treatment Outcome | 3 | 2018 | 63119 | 0.050 |
Why?
|
Receptors, Dopamine | 2 | 1991 | 295 | 0.050 |
Why?
|
Citalopram | 1 | 2003 | 404 | 0.050 |
Why?
|
Neural Pathways | 2 | 2022 | 2972 | 0.050 |
Why?
|
Tetrahydronaphthalenes | 1 | 2000 | 89 | 0.050 |
Why?
|
Benzodiazepinones | 1 | 1999 | 51 | 0.040 |
Why?
|
Cues | 2 | 2016 | 873 | 0.040 |
Why?
|
GABA-A Receptor Antagonists | 1 | 1999 | 62 | 0.040 |
Why?
|
Pharmacological Phenomena | 1 | 2019 | 11 | 0.040 |
Why?
|
Behavioral Sciences | 1 | 2019 | 31 | 0.040 |
Why?
|
Stress, Psychological | 1 | 2014 | 4245 | 0.040 |
Why?
|
Schizophrenia | 1 | 2017 | 6882 | 0.040 |
Why?
|
Evoked Potentials, Visual | 1 | 2021 | 427 | 0.040 |
Why?
|
Sleep, REM | 1 | 2022 | 595 | 0.040 |
Why?
|
Recurrence | 2 | 2024 | 8343 | 0.040 |
Why?
|
Ergolines | 1 | 1998 | 61 | 0.040 |
Why?
|
Heart Rate | 2 | 2007 | 4092 | 0.040 |
Why?
|
Drug Agonism | 1 | 2017 | 2 | 0.040 |
Why?
|
Adrenergic Agents | 1 | 1998 | 70 | 0.040 |
Why?
|
Free Radical Scavengers | 1 | 2019 | 216 | 0.040 |
Why?
|
Infusions, Subcutaneous | 1 | 2017 | 42 | 0.040 |
Why?
|
United States | 3 | 2014 | 69867 | 0.040 |
Why?
|
Drug Antagonism | 1 | 2017 | 50 | 0.040 |
Why?
|
Glycerides | 1 | 2017 | 71 | 0.040 |
Why?
|
Serotonin 5-HT2 Receptor Agonists | 1 | 2017 | 38 | 0.040 |
Why?
|
Binding Sites | 3 | 1999 | 6116 | 0.040 |
Why?
|
Mice, 129 Strain | 1 | 2018 | 386 | 0.040 |
Why?
|
Vomiting | 1 | 2020 | 635 | 0.040 |
Why?
|
Models, Molecular | 2 | 2020 | 5458 | 0.040 |
Why?
|
Bupropion | 2 | 1989 | 303 | 0.040 |
Why?
|
Imidazoles | 1 | 2003 | 1206 | 0.040 |
Why?
|
Task Performance and Analysis | 1 | 2021 | 780 | 0.040 |
Why?
|
Thiophenes | 1 | 2001 | 589 | 0.030 |
Why?
|
Codeine | 1 | 1996 | 49 | 0.030 |
Why?
|
Arousal | 1 | 2022 | 1165 | 0.030 |
Why?
|
Psychiatry | 1 | 2008 | 1695 | 0.030 |
Why?
|
Rats, Wistar | 1 | 1999 | 1903 | 0.030 |
Why?
|
Myocardium | 1 | 1988 | 4776 | 0.030 |
Why?
|
Receptors, Drug | 2 | 1992 | 161 | 0.030 |
Why?
|
Pyrroles | 1 | 2001 | 1143 | 0.030 |
Why?
|
Gyrus Cinguli | 1 | 2020 | 1091 | 0.030 |
Why?
|
Models, Animal | 1 | 2021 | 2171 | 0.030 |
Why?
|
Flupenthixol | 1 | 1993 | 12 | 0.030 |
Why?
|
Stimulation, Chemical | 1 | 1993 | 326 | 0.030 |
Why?
|
Serine | 1 | 2017 | 828 | 0.030 |
Why?
|
Salicylamides | 1 | 1993 | 33 | 0.030 |
Why?
|
Carbon Dioxide | 2 | 1996 | 1147 | 0.030 |
Why?
|
Cannabis | 1 | 2020 | 438 | 0.030 |
Why?
|
Protein Isoforms | 1 | 2018 | 1731 | 0.030 |
Why?
|
Autoantigens | 1 | 2017 | 892 | 0.030 |
Why?
|
Anticonvulsants | 1 | 2003 | 1917 | 0.030 |
Why?
|
Rats, Long-Evans | 1 | 2013 | 387 | 0.030 |
Why?
|
Isoquinolines | 1 | 1994 | 368 | 0.030 |
Why?
|
Mice, Knockout | 2 | 2018 | 14556 | 0.030 |
Why?
|
Drug Therapy | 1 | 2015 | 497 | 0.030 |
Why?
|
Glutamic Acid | 1 | 2017 | 1169 | 0.030 |
Why?
|
Marijuana Abuse | 1 | 2016 | 403 | 0.030 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2017 | 1123 | 0.020 |
Why?
|
Biocatalysis | 1 | 2012 | 167 | 0.020 |
Why?
|
Hemodynamics | 1 | 2002 | 4199 | 0.020 |
Why?
|
Indans | 1 | 1992 | 96 | 0.020 |
Why?
|
Evaluation Studies as Topic | 1 | 1994 | 1676 | 0.020 |
Why?
|
Analgesia | 1 | 1996 | 462 | 0.020 |
Why?
|
Radioligand Assay | 1 | 1991 | 379 | 0.020 |
Why?
|
Half-Life | 1 | 2012 | 659 | 0.020 |
Why?
|
Personality | 1 | 2014 | 552 | 0.020 |
Why?
|
Pyrilamine | 1 | 1990 | 12 | 0.020 |
Why?
|
Interpersonal Relations | 1 | 2018 | 1424 | 0.020 |
Why?
|
Astrocytes | 1 | 2018 | 1270 | 0.020 |
Why?
|
Mazindol | 1 | 1989 | 13 | 0.020 |
Why?
|
Nomifensine | 1 | 1989 | 15 | 0.020 |
Why?
|
Posture | 1 | 1994 | 958 | 0.020 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2005 | 3658 | 0.020 |
Why?
|
Fear | 1 | 2018 | 1439 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2020 | 2569 | 0.020 |
Why?
|
Head | 1 | 1994 | 880 | 0.020 |
Why?
|
Cyproheptadine | 1 | 1988 | 21 | 0.020 |
Why?
|
Putamen | 1 | 1989 | 291 | 0.020 |
Why?
|
Caudate Nucleus | 1 | 1989 | 393 | 0.020 |
Why?
|
Carrier Proteins | 2 | 1992 | 5021 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2022 | 12035 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2024 | 9438 | 0.020 |
Why?
|
Heart Septum | 1 | 1988 | 313 | 0.020 |
Why?
|
Movement | 1 | 1994 | 1471 | 0.020 |
Why?
|
Tripelennamine | 1 | 1986 | 6 | 0.020 |
Why?
|
Sex Factors | 1 | 2021 | 10396 | 0.020 |
Why?
|
Promethazine | 1 | 1986 | 29 | 0.020 |
Why?
|
Antibody Formation | 1 | 2012 | 1402 | 0.020 |
Why?
|
Cimetidine | 1 | 1986 | 78 | 0.020 |
Why?
|
Secondary Prevention | 1 | 2013 | 1531 | 0.020 |
Why?
|
Diphenhydramine | 1 | 1986 | 63 | 0.020 |
Why?
|
Indoles | 1 | 1995 | 1838 | 0.020 |
Why?
|
Child Behavior | 1 | 2012 | 838 | 0.020 |
Why?
|
Lithium Chloride | 1 | 1986 | 87 | 0.020 |
Why?
|
Molecular Biology | 1 | 2010 | 596 | 0.020 |
Why?
|
Phenazocine | 1 | 1985 | 7 | 0.020 |
Why?
|
Thiazoles | 1 | 2013 | 1484 | 0.020 |
Why?
|
Sleep | 1 | 2022 | 4623 | 0.020 |
Why?
|
Hippocampus | 1 | 2018 | 3676 | 0.020 |
Why?
|
Brain Mapping | 1 | 2020 | 6671 | 0.020 |
Why?
|
Propylamines | 1 | 2005 | 165 | 0.020 |
Why?
|
Infusion Pumps | 1 | 2005 | 163 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 2 | 2022 | 35423 | 0.010 |
Why?
|
Sulfonamides | 1 | 2013 | 1940 | 0.010 |
Why?
|
Adolescent Behavior | 1 | 2012 | 1151 | 0.010 |
Why?
|
Nordazepam | 1 | 2003 | 5 | 0.010 |
Why?
|
Anorexia Nervosa | 1 | 2012 | 1286 | 0.010 |
Why?
|
Comorbidity | 1 | 2017 | 10387 | 0.010 |
Why?
|
Myocardial Contraction | 1 | 1988 | 1585 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2021 | 19907 | 0.010 |
Why?
|
Neuronal Plasticity | 1 | 2010 | 1422 | 0.010 |
Why?
|
Food Deprivation | 1 | 1981 | 116 | 0.010 |
Why?
|
Epigenesis, Genetic | 1 | 2014 | 3646 | 0.010 |
Why?
|
Phenotype | 1 | 2018 | 16365 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2012 | 8628 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2018 | 21824 | 0.010 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2003 | 1574 | 0.010 |
Why?
|
Blood Pressure | 2 | 2007 | 8551 | 0.010 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2014 | 4266 | 0.010 |
Why?
|
Heart Ventricles | 1 | 1988 | 3820 | 0.010 |
Why?
|
Echocardiography | 1 | 1988 | 5103 | 0.010 |
Why?
|
Depression | 1 | 2014 | 7767 | 0.010 |
Why?
|
Diet | 1 | 2012 | 7937 | 0.010 |
Why?
|
Adult | 2 | 2022 | 214035 | 0.010 |
Why?
|
Cyclic AMP | 1 | 1997 | 1471 | 0.010 |
Why?
|
Levodopa | 1 | 1991 | 219 | 0.010 |
Why?
|
Macaca fascicularis | 1 | 1989 | 910 | 0.000 |
Why?
|
Infant | 1 | 1988 | 35129 | 0.000 |
Why?
|
Child, Preschool | 1 | 1988 | 40992 | 0.000 |
Why?
|
Child | 1 | 2012 | 77679 | 0.000 |
Why?
|
Adolescent | 1 | 2012 | 85759 | 0.000 |
Why?
|